English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Eli Lilly And Company Lilly
Press release submission
| Nov 19, 2021
Emgality® Versus Nurtec® ODT Head-to-Head Migraine Preventive Treatment Study Now Enrolling Patients
Trending
+
Pharmaceuticals
Patient Daily
| Jun 18, 2025
ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+
Pharmaceuticals
Patient Daily
| Jun 16, 2025
American Consumer Institute questions hospital use of 340B Drug Pricing Program
+
Pharmaceuticals
Patient Daily
| Jun 13, 2025
Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’
+
Pharmaceuticals
Patient Daily
| Jun 19, 2025
Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
